• Login
  • Help Guide
View Item 
  •   JOOUST IR Home
  • Journal Articles
  • School of Agriculture and Food Science
  • View Item
  •   JOOUST IR Home
  • Journal Articles
  • School of Agriculture and Food Science
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

High Seroprevalence of Immunoglobulin G (Igg) and 2 Igm Antibodies to SARS-Cov-2 in Asymptomatic and 3 Symptomatic Individuals amidst Vaccination Roll-Out 4 in Western Kenya

Thumbnail
View/Open
Awandu_High Seroprevalence of Immunoglobulin G (Igg) and 2 Igm Antibodies to SARS-Cov-2 in Asymptomatic and 3 Symptomatic Individuals amidst Vaccination Roll-Out 4 in Western Kenya.pdf (700.7Kb)
Publication Date
2022-07
Author
Awandu, Shehu Shagari
Ochieng, Alfred
Onyango, Benson
Odongo, Richard Magwanga
Were, Pamella
Ochun, Angeline
Okumu, Fredrick
Oloo, Marceline Adhiambo
Katieno, Jim Seth
Lidechi, Shirley
Ogutu, Fredrick
Awuor, Dorothy
Kirungu, Joy Nyangasi
Omoto, Francis Orata
Midega, Justine
Oure, Bonface
Nyunja, Regina
Muok, Eric M O
Munga, Steven
Estambale, Benson
Type
Article
Metadata
Show full item record
Abstract/Overview

The population's antibody response is a key factor in comprehending SARS-CoV-2 epidemiology. This is especially important in African settings where COVID-19 impact, and vaccination rates are relatively low. This study aimed at characterizing the Immunoglobulin G (IgG) and Immunoglobulin M (IgM) in both SARS-CoV-2 asymptomatic and symptomatic individuals in Kisumu and Siaya counties in Western Kenya using enzyme linked immunosorbent assays. The IgG and IgM overall seroprevalence in symptomatic and asymptomatic individuals in western Kenya between December 2021-March 2022 was 76.5% (95%CI =66.9-84.5) and 31.6% (95% CI =22.6- 41.8) respectively. In terms of gender, males had slightly higher IgG positivity 87.8% (36/41) than females 68.4% (39/57). Amidst the ongoing vaccination roll-out during the study period, over half of the study participants (55.1%, 95% CI= 44.7-65.2) had not received any vaccine. About one third, (30.6%, 95% CI= 21.7-40.7) of the study participants had been fully vaccinated, with close to a quarter (14.3% 95% CI=8.04-22.8) partially vaccinated. When considering the vaccination status and seroprevalence, out of the 30 fully vaccinated individuals, IgG seropositivity was 86.7% (95% CI =69.3-96.2) and IgM seropositivity was 40% (95% CI =22.7-59.4). Out of the participants that had not been vaccinated at all, IgG seroprevalence was 70.3% (95% CI 56.4-82.0) with 20.4% (95% CI 10.6-33.5) seropositivity of IgM antibodies. SARs-CoV-2 PCR positivity did not significantly predict IgG (p = 0.457 [95% CI 0.514- 4.371]) and IgM (p = 0.858 [95% CI 0.350-2.395]) positivity. .CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review). The copyright holder for this preprintthis version posted July 29, 2022.;https://doi.org/10.1101/2022.07.27.22278095doi:medRxiv preprint Our data indicate a high seroprevalence of antibodies to SARS-CoV-2 in western Kenya. This suggests larger fraction of the population were infected with SARS-CoV-2 within the defined period than what PCR testing could cover.

Publisher
medRxiv
Permalink
http://ir.jooust.ac.ke:8080/xmlui/handle/123456789/11146
Collections
  • School of Agriculture and Food Science [179]

Browse

All of JOOUST IRCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Statistics

View Usage Statistics

Contact Us

Copyright © 2023-4 Jaramogi Oginga Odinga University of Science and Technology (JOOUST)
P.O. Box 210 - 40601
Bondo – Kenya

Useful Links

  • Report a problem with the content
  • Accessibility Policy
  • Deaccession/Takedown Policy

TwitterFacebookYouTubeInstagram

  • University Policies
  • Access to Information
  • JOOUST Quality Statement